Technology Strategy

R & DCore TechnologyHigh-Compact Technology Strategy

High-Compact Technology Strategy in Stem Cells, SELAFTM

SELAFTM is one-stop platform optimized for stem cells from the procedures of separation and production to clinical trials.
Using this platform, it is possible to mass-produce and freeze immune-specific stem cells with high NOD2, the immune-modulator in the body. It can be immediately injected after thawing at site.

rnd : technologies_selaf : : : /rnd/technologies_selaf